Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Breunig

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Nephrology|February 12, 2008
Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapyFrank Breunig, Christoph Wanner
Medizinische Klinik (Munich, Germany : 1983)|March 18, 2008
[Cardiac involvement in Fabry's disease]Frank Weidemann, Frank Breunig
Current Opinion in Nephrology and Hypertension|August 16, 2003
Enzyme replacement therapy in Fabry disease: clinical implicationsFrank Breunig, Anita Knoll, Christoph Wanner
European Journal of Clinical Investigation|November 5, 2011
Interdisciplinary approach towards female patients with Fabry diseaseFrank Weidemann, Markus Niemann, Claudia Sommer, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 30, 2010
[Females with Fabry's disease - an interdisciplinary diagnostic and therapeutic challenge]Frank Weidemann, Markus Niemann, Claudia Sommer, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|February 28, 2012
Cerebral blood flow in patients with Fabry disease as measured by Doppler sonography is not different from that in healthy individuals and is unaffected by treatmentNurcan Uçeyler, Lan He, Ann-Kathrin Kahn, et al.
BMC Nephrology|November 30, 2014
Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry diseaseMartin Wagner, Johannes Krämer, Elisabeth Blohm, et al.
JIMD Reports|February 23, 2013
Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry DiseaseMarkus Niemann, Arndt Rolfs, Anne Giese, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapyRenzo Mignani, Sandro Feriozzi, Roland M Schaefer, et al.
Rapid Communications in Mass Spectrometry : RCM|May 10, 2005
Rapid determination of urinary globotriaosylceramide isoform profiles by electrospray ionization mass spectrometry using stearoyl-d35-globotriaosylceramide as internal standardGuenter Fauler, Gerald N Rechberger, Danijela Devrnja, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Nephrology|February 12, 2008
Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapyFrank Breunig, Christoph Wanner
Medizinische Klinik (Munich, Germany : 1983)|March 18, 2008
[Cardiac involvement in Fabry's disease]Frank Weidemann, Frank Breunig
Current Opinion in Nephrology and Hypertension|August 16, 2003
Enzyme replacement therapy in Fabry disease: clinical implicationsFrank Breunig, Anita Knoll, Christoph Wanner
European Journal of Clinical Investigation|November 5, 2011
Interdisciplinary approach towards female patients with Fabry diseaseFrank Weidemann, Markus Niemann, Claudia Sommer, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 30, 2010
[Females with Fabry's disease - an interdisciplinary diagnostic and therapeutic challenge]Frank Weidemann, Markus Niemann, Claudia Sommer, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|February 28, 2012
Cerebral blood flow in patients with Fabry disease as measured by Doppler sonography is not different from that in healthy individuals and is unaffected by treatmentNurcan Uçeyler, Lan He, Ann-Kathrin Kahn, et al.
BMC Nephrology|November 30, 2014
Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry diseaseMartin Wagner, Johannes Krämer, Elisabeth Blohm, et al.
JIMD Reports|February 23, 2013
Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry DiseaseMarkus Niemann, Arndt Rolfs, Anne Giese, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapyRenzo Mignani, Sandro Feriozzi, Roland M Schaefer, et al.
Rapid Communications in Mass Spectrometry : RCM|May 10, 2005
Rapid determination of urinary globotriaosylceramide isoform profiles by electrospray ionization mass spectrometry using stearoyl-d35-globotriaosylceramide as internal standardGuenter Fauler, Gerald N Rechberger, Danijela Devrnja, et al.
Pageof 4